0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Human Health Effects Policy & Risk Sign in to save

Synergistic effects of microplastics and bioaerosols: emerging trends in urban air pollution complexification and public health implications

Environmental Research 2025 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 53 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Lei Chen, Shanshan Zhao, Xiaokun Li, Xilong Wang, Guanliu Yu

Summary

This review examines the emerging synergistic health risks of airborne microplastics and bioaerosols in urban environments. Researchers found that microplastics can serve as carriers for bacteria, fungi, and viruses, potentially prolonging pathogen survival and increasing human exposure through inhalation. The combined exposure may amplify respiratory inflammation and oxidative stress beyond what either pollutant causes individually, highlighting a growing concern for urban public health.

Urban air is increasingly contaminated with complex mixtures of microplastics (MPs) and bioaerosols (BAs), whose co-exposure may pose unique health risks. This review highlights the synergistic interaction between MPs and BAs during atmospheric transport and human exposure. We summarized the sources and physicochemical characteristics of airborne MPs (fragments and fibers from urban waste and textiles) and BAs (bacteria, fungi, and viruses from soil, water, and human activity) and their shared dispersion pathways via wind and resuspension. Both pollutants deposit in the respiratory tract upon inhalation. Notably, MPs may function as potential microbial carriers. Laboratory and field data indicate that airborne plastics harbor distinct microbial biofilms (often with antibiotic-resistant bacteria/genes) and may prolong virus survival (e.g., SARS-CoV-2 on plastic surfaces). These MP-microbe aggregates can enhance pathogen persistence and increase host exposure. In lung models, inhaled MPs disrupt epithelial barriers and surfactant layers, inhibit cell proliferation, and trigger inflammation (tumor necrosis factor-alpha, interleukin-6, IL-1β, and tumor growth factor-beta) and oxidative stress (depleting SOD/CAT and generating reactive oxygen species). Assessing this co-pollution requires advanced methods. Standard spectroscopic tools (micro-Fourier-transform infrared spectroscopy and micro-Raman) and emerging methods such as laser direct infrared imaging enable polymer identification and MP sizing. Similarly, culture-independent high-throughput sequencing techniques (e.g., 16S/18S rRNA gene profiling) elucidate airborne microbial diversity. Novel real-time aerosol counters (e.g., UV-LIF optical sensors) and machine learning analytics are being applied to monitor BA load. Finally, we discussed implications for vulnerable subpopulations (children, the elderly, and individuals with chronic respiratory conditions) who may be more susceptible to combined MP/BA effects. The review proposes future directions, which include developing integrated toxicological models, multi-omics analyses of particle-microbe interactions, and establishing coordinated environmental health surveillance to track this emerging urban pollutant mixture.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

An emerging class of air pollutants: Potential effects of microplastics to respiratory human health?

This review explores the emerging concern that airborne microplastics can be inhaled by humans, potentially causing adverse effects on the respiratory system. Researchers compiled available data on the concentration, size, shape, and chemical composition of microplastic particles found in urban air. The findings suggest that airborne plastic debris represents a largely understudied class of air pollutant with potential implications for human health.

Article Tier 2

Suspended fine particulate matter (PM2.5), microplastics (MPs), and polycyclic aromatic hydrocarbons (PAHs) in air: Their possible relationships and health implications

Researchers analyzed the relationship between airborne fine particulate matter, microplastics, and toxic chemicals in an urban area near the Persian Gulf. They found microplastics embedded in air pollution particles, suggesting that people may be inhaling microplastics along with other air pollutants, with potential combined health effects that warrant further investigation.

Article Tier 2

Airborne microplastics and human health in urban environments

This review examines the sources, concentrations, and health impacts of airborne microplastics in urban environments across cities including Paris, London, Shanghai, and Delhi, covering respiratory inflammation, oxidative stress, and systemic toxicity associated with indoor and outdoor microplastic inhalation.

Article Tier 2

Potential planetary health impacts of the airborne plastisphere

Researchers reviewed emerging evidence that airborne microplastics can carry and transport living microorganisms — including potential pathogens and antibiotic-resistant bacteria — across long distances through the atmosphere, identifying this as an overlooked global health threat that bridges pollution and infectious disease.

Article Tier 2

Microplastics in the urban atmosphere: Sources, occurrences, distribution, and potential health implications

This review summarizes research on airborne microplastics in cities, finding that indoor sources like textiles and outdoor sources like traffic-related plastic particles are major contributors. Microplastic concentrations in urban air can be significant, especially in densely populated areas, and people can inhale these particles daily. The health implications of breathing in microplastics are still being studied, but early evidence suggests they may cause lung inflammation and other respiratory problems.

Share this paper